Yellon D M, Hearse D J, Maxwell M P, Chambers D E, Downey J M
Am J Cardiol. 1983 May 1;51(8):1409-13. doi: 10.1016/0002-9149(83)90321-1.
Studies were undertaken to ascertain whether verapamil infusion affords a sustained limitation of myocardial injury in the dog after a 24-hour period of coronary artery occlusion. Regional myocardial ischemia was induced by an embolization procedure which did not involve thoracotomy. Immediately after embolization radioactive microspheres were administered intraventricularly to define any area of myocardial underperfusion (zone at risk of infarction). Verapamil (0.005 mg/kg/min) was then administered and maintained for 24 hours during which time the dogs were allowed to recover from anesthesia. The control group received a corresponding infusion of saline solution. After 24 hours the dogs were killed and transverse myocardial sections (3 mm) were prepared. The resulting area of necrosis was visualized by tetrazolium staining, and risk zones were visualized by autoradiography. In the control heart, 62 +/- 7% of the zone at risk deteriorated to necrotic tissue, whereas in the verapamil-treated group only 18 +/- 4% of the tissue in the zone at risk became necrotic. Verapamil appeared to exert a significant (p less than 0.001) tissue-sparing effect that was sustained for at least 24 hours after the onset of ischemia.
开展了多项研究,以确定在冠状动脉闭塞24小时后,静脉输注维拉帕米是否能持续限制犬心肌损伤。通过不涉及开胸手术的栓塞程序诱导局部心肌缺血。栓塞后立即经心室内注射放射性微球,以确定心肌灌注不足的任何区域(梗死风险区)。然后给予维拉帕米(0.005mg/kg/min)并维持24小时,在此期间让犬从麻醉中恢复。对照组接受相应的生理盐水输注。24小时后处死犬,制备横断心肌切片(3mm)。通过四氮唑染色观察坏死面积,通过放射自显影观察风险区。在对照心脏中,62±7%的风险区恶化为坏死组织,而在维拉帕米治疗组中,风险区内只有18±4%的组织发生坏死。维拉帕米似乎具有显著的(p<0.001)组织保护作用,且在缺血开始后至少24小时内持续存在。